This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Abbreviation | TT |
---|---|
Formation | 1999 |
Legal status | Registered charity |
Purpose | Improves the early detection and care of babies with serious heart conditions. |
Location |
|
Region served | UK |
Chief Executive | Jon Arnold |
Website | Tiny Tickers |
Tiny Tickers is a charitable organisation [1] in the United Kingdom that aims to improve the early detection, diagnosis, and care of babies with congenital heart disease through a combination of improving standards, providing specialised training and equipment, spreading awareness of congenital heart disease and supporting families.
Tiny Tickers charity was founded in 1999 by world-renowned fetal cardiologist Dr Helena Gardiner, when she realised many of the babies she was caring for could have been helped earlier. She had experience of, and was concerned about, the low prenatal detection rate of congenital heart disease (CHD).
1 in every 125 babies born in the UK has a serious heart condition, which is around one baby born every two hours fighting congenital heart disease (CHD). Tiny Tickers is the only UK charity dedicated to the early detection and care of those babies. Spotting a heart defect early improves a baby's chances of survival and long-term quality of life. 1,000 heart babies leave UK hospitals every year with no-one knowing they have a life-threatening heart condition, putting them in grave danger of going into heart failure.
Tiny Tickers trains sonographers to have the skills and confidence to detect heart defects at pregnancy scans. The antenatal detection rate of heart defects in the UK has more than doubled from 23% to 53.5% since they started their work (NICOR).
Tiny Tickers also places potentially life-saving pulse oximetry machines in maternity wards to further improve the early detection of CHD.
Pulse oximetry testing helps to detect heart defects by measuring oxygen levels (oxygen saturation) in the blood. It uses a light sensor to assess the level of oxygen in the baby’s blood. Not every baby will be born displaying signs and symptoms and with this machine many more life-threatening defects can be detected.
At present, pulse oximetry testing is not a mandatory newborn test within NHS hospitals, and many maternity units do not have the means to introduce these life-saving machines. For these reasons, Tiny Tickers places pulse oximetry testing kits in maternity units across the UK which can then be used as part of standard newborn tests.
The charity teaches new parents and those working with babies to recognise the five key signs a baby may have an undiagnosed heart defect (Think HEART).
Another core part of the charity's work is supporting the families of babies with CHD. They provide detailed information, share CHD stories and connect heart parents through support group forums and peer support groups.
Tiny Tickers receives no government funding. The charity is entirely funded by the generosity of individuals and grant makers.
Tiny Tickers has featured in a number of high profile media campaigns, including a 2017 BBC Lifeline appeal and a 2023 Global's Make Some Noise Appeal, where charity staff and supporters were interviewed on Heart Radio by Amanda Holden and Jamie Theakston.
Patent ductus arteriosus (PDA) is a medical condition in which the ductus arteriosus fails to close after birth: this allows a portion of oxygenated blood from the left heart to flow back to the lungs through the aorta, which has a higher blood pressure, to the pulmonary artery, which has a lower blood pressure. Symptoms are uncommon at birth and shortly thereafter, but later in the first year of life there is often the onset of an increased work of breathing and failure to gain weight at a normal rate. With time, an uncorrected PDA usually leads to pulmonary hypertension followed by right-sided heart failure.
dextro-Transposition of the great arteries is a potentially life-threatening birth defect in the large arteries of the heart. The primary arteries are transposed.
Blue baby syndrome can refer to conditions that cause cyanosis, or blueness of the skin, in babies as a result of low oxygen levels in the blood. This term has traditionally been applied to cyanosis as a result of:.
Newborn screening (NBS) is a public health program of screening in infants shortly after birth for conditions that are treatable, but not clinically evident in the newborn period. The goal is to identify infants at risk for these conditions early enough to confirm the diagnosis and provide intervention that will alter the clinical course of the disease and prevent or ameliorate the clinical manifestations. NBS started with the discovery that the amino acid disorder phenylketonuria (PKU) could be treated by dietary adjustment, and that early intervention was required for the best outcome. Infants with PKU appear normal at birth, but are unable to metabolize the essential amino acid phenylalanine, resulting in irreversible intellectual disability. In the 1960s, Robert Guthrie developed a simple method using a bacterial inhibition assay that could detect high levels of phenylalanine in blood shortly after a baby was born. Guthrie also pioneered the collection of blood on filter paper which could be easily transported, recognizing the need for a simple system if the screening was going to be done on a large scale. Newborn screening around the world is still done using similar filter paper. NBS was first introduced as a public health program in the United States in the early 1960s, and has expanded to countries around the world.
Pulse oximetry is a noninvasive method for monitoring blood oxygen saturation. Peripheral oxygen saturation (SpO2) readings are typically within 2% accuracy of the more accurate reading of arterial oxygen saturation (SaO2) from arterial blood gas analysis.
A congenital heart defect (CHD), also known as a congenital heart anomaly, congenital cardiovascular malformation, and congenital heart disease, is a defect in the structure of the heart or great vessels that is present at birth. A congenital heart defect is classed as a cardiovascular disease. Signs and symptoms depend on the specific type of defect. Symptoms can vary from none to life-threatening. When present, symptoms are variable and may include rapid breathing, bluish skin (cyanosis), poor weight gain, and feeling tired. CHD does not cause chest pain. Most congenital heart defects are not associated with other diseases. A complication of CHD is heart failure.
At the end of pregnancy, the fetus must take the journey of childbirth to leave the reproductive mother. Upon its entry to the air-breathing world, the newborn must begin to adjust to life outside the uterus. This is true for all viviparous animals; this article discusses humans as the most-researched example.
Capnography is the monitoring of the concentration or partial pressure of carbon dioxide (CO
2) in the respiratory gases. Its main development has been as a monitoring tool for use during anesthesia and intensive care. It is usually presented as a graph of CO
2 (measured in kilopascals, "kPa" or millimeters of mercury, "mmHg") plotted against time, or, less commonly, but more usefully, expired volume (known as volumetric capnography). The plot may also show the inspired CO
2, which is of interest when rebreathing systems are being used. When the measurement is taken at the end of a breath (exhaling), it is called "end tidal" CO
2 (PETCO2).
A neonatal intensive care unit (NICU), also known as an intensive care nursery (ICN), is an intensive care unit (ICU) specializing in the care of ill or premature newborn infants. The NICU is divided into several areas, including a critical care area for babies who require close monitoring and intervention, an intermediate care area for infants who are stable but still require specialized care, and a step down unit where babies who are ready to leave the hospital can receive additional care before being discharged.
Action Medical Research, previously The National Fund for Research into Crippling Diseases, is a major British medical research charity, founded in 1952, that funds research to prevent and treat disease and disability in babies and children.
Heart Research UK is a national charity organisation in the United Kingdom. They fund medical research in to the prevention, treatment and cure of heart disease, as well as community projects aimed at improving the public's heart health. Since its foundation, Heart Research UK has funded over £25 million of research into heart disease and related conditions.
Transposition of the great vessels (TGV) is a group of congenital heart defects involving an abnormal spatial arrangement of any of the great vessels: superior and/or inferior venae cavae, pulmonary artery, pulmonary veins, and aorta. Congenital heart diseases involving only the primary arteries belong to a sub-group called transposition of the great arteries (TGA), which is considered the most common congenital heart lesion that presents in neonates.
Pulmonary atresia is a congenital malformation of the pulmonary valve in which the valve orifice fails to develop. The valve is completely closed thereby obstructing the outflow of blood from the heart to the lungs. The pulmonary valve is located on the right side of the heart between the right ventricle and pulmonary artery. In a normal functioning heart, the opening to the pulmonary valve has three flaps that open and close.
Neonatal nursing is a sub-specialty of nursing care for newborn infants up to 28 days after birth. The term neonatal comes from neo, "new", and natal, "pertaining to birth or origin". Neonatal nursing requires a high degree of skill, dedication and emotional strength as they care for newborn infants with a range of problems. These problems vary between prematurity, birth defects, infection, cardiac malformations and surgical issues. Neonatal nurses are a vital part of the neonatal care team and are required to know basic newborn resuscitation, be able to control the newborn's temperature and know how to initiate cardiopulmonary and pulse oximetry monitoring. Most neonatal nurses care for infants from the time of birth until they are discharged from the hospital.
Masimo Corporation is a health technology and consumer electronics company based in Irvine, California. The company primarily manufactures patient monitoring devices and technologies, including non-invasive sensors using optical technology, patient management, and telehealth platforms. In 2022, the company expanded into home audio by acquiring Sound United, and began to manufacture health-oriented wearable devices.
Fetal echocardiography, or Fetal echocardiogram, is the name of the test used to diagnose cardiac conditions in the fetal stage. Cardiac defects are amongst the most common birth defects. Their diagnosis is important in the fetal stage as it might help provide an opportunity to plan and manage the baby as and when the baby is born. Not all pregnancies need to undergo fetal echo.
The Newborn Screening Saves Lives Reauthorization Act of 2014 is a bill that would amend the Public Health Service Act to reauthorize grant programs and other initiatives to promote expanded screening of newborns and children for heritable disorders.
The Newborn Foundation is a Minnesota-based international 501(c)(3) non-profit organization that advocates for newborn screening and works to develop and implement programs, technologies and policies that reduce infant mortality. The organization has played a part in the addition of universal newborn pulse oximetry (CCHD) screening to the federal Routine Uniform Screening Panel (RUSP).
Annamarie Saarinen is an American health advocate, economist and co-founder of the Newborn Foundation, a 501(c)(3) organization that aims to accelerate the pace of early detection and intervention for treatable newborn health conditions.